CORONA Remedies Limited (CORONA) Share Analysis
NSE · Healthcare · Healthcare
CORONA Remedies Limited (NSE: CORONA) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹2,202.00, market capitalisation ₹13,466 Cr, P/E 63.5, ROE 29.5%.
Get the AI verdict on CORONA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
CORONA price and valuation
- Share price
- ₹2,202.00
- Market cap
- ₹13,466 Cr
- P/E ratio
- 63.5
- P/B ratio
- 18.05
- EPS
- ₹32.54
- Book value per share
- ₹122.00
- Dividend yield
- 0.45%
CORONA profitability and growth
- ROE
- 29.5%
- ROCE
- 33.3%
- Debt to equity
- 0.22
- Revenue growth (3 yr)
- 17%
- Revenue growth (5 yr)
- -
- Profit growth (3 yr)
- 33%
- Profit growth (5 yr)
- -
CORONA 52-week range
- 52-week high
- ₹2,292.40
- 52-week low
- ₹1,336.60
- Face value
- ₹10.00
CORONA shareholding pattern
- Promoters
- 69%
- FIIs
- 3.63%
- DIIs
- 12.9%
- Public
- 14.47%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.